Literature DB >> 28616279

Benefits of a right anterolateral minithoracotomy rather than a median sternotomy in isolated tricuspid redo procedures.

Aikebaier Maimaiti1,2, Lai Wei1, Ye Yang1, Huan Liu1, Chunsheng Wang1.   

Abstract

BACKGROUND: To compare results of tricuspid valve (TV) reoperation between incision via a right anterolateral minithoracotomy (RAMT) and median sternotomy (MS).
METHODS: We performed a retrospective analysis of 49 patients who underwent isolated TV surgery as a reoperation at our institution between 2006 and 2015. Previous cardiac operations included mitral, aortic, and TV surgeries, atrial septal defect repair, and pericardiectomy. The mean age of the patients was 51.9±12.8 years, 14 (28%) were male and 35 (72%) were female. Follow-up was 95% (38/40) complete, with a mean duration of 41.3±19.5 months.
RESULTS: Perioperative demographic and laboratory tests did not show any significant differences between the RAMT and MS groups. The drainage volume, total red cell unit, total serum volume and platelet were significantly different 1150±803.5/2,270±1,920, 4.8±4.1/8.7±8.9, 478.2±488.9/950.0±857.6, 0.04±0.21/0.38±0.64 (P<0.05), while other perioperative data were similar. There were no significant differences in early postoperative death and complications between the RAMT and MS groups. A multivariate linear regression analysis predicted that serum creatinine (Scr), age, and MS group were independent risk factors for bleeding. The Cox regression demonstrated that the MS group had a longer drainage duration (P<0.05) and had a relative hazardous risk (HR) of 2.691 (1.328, 5.450 CI) compared with the RAMT group.
CONCLUSIONS: The RAMT approach is an alternative, safe, and feasible procedure for isolated TV reoperation. It has the advantages of less drainage and reduced requirement for blood products.

Entities:  

Keywords:  Retrospective; isolated tricuspid operation; minimally invasive; redo

Year:  2017        PMID: 28616279      PMCID: PMC5465167          DOI: 10.21037/jtd.2017.04.50

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  14 in total

1.  Should a video-assisted mini-thoracotomy be the approach of choice for reoperative mitral valve surgery?

Authors:  Gil Bolotin; Alan P Kypson; Clifton C Reade; Victor F Chu; William L Freund; L Wiley Nifong; W Randolph Chitwood
Journal:  J Heart Valve Dis       Date:  2004-03

2.  Rheumatic heart disease in developing countries.

Authors:  Stanford T Shulman
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

3.  Impact of tricuspid regurgitation after redo valvular surgery on survival in patients with previous mitral valve replacement.

Authors:  Naoto Fukunaga; Yukikatsu Okada; Yasunobu Konishi; Takashi Murashita; Hideo Kanemitsu; Tadaaki Koyama
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-12       Impact factor: 5.209

Review 4.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Mark A Creager; Lesley H Curtis; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; William G Stevenson; Clyde W Yancy
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-09       Impact factor: 5.209

5.  Tricuspid reoperation after left-sided rheumatic valve operations.

Authors:  Dong Seop Jeong; Pyo Won Park; Tom Philip Mwambu; Kiick Sung; Wook Sung Kim; Young Tak Lee; Sung-Ji Park; Seung Woo Park
Journal:  Ann Thorac Surg       Date:  2013-04-23       Impact factor: 4.330

6.  Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study.

Authors:  Lars Englberger; Thierry P Carrel; Mirko Doss; Jerzy Sadowski; Krzysztof Bartus; Friedrich F Eckstein; Federico M Asch; Sven Martens
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-04       Impact factor: 5.209

7.  Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair.

Authors:  Jamil Aboulhosn; Allison K Cabalka; Daniel S Levi; Dominique Himbert; Luca Testa; Azeem Latib; Raj R Makkar; Younes Boudjemline; Dennis W Kim; Joelle Kefer; Sabine Bleiziffer; Gunter Kerst; Danny Dvir; Doff B McElhinney
Journal:  JACC Cardiovasc Interv       Date:  2017-01-09       Impact factor: 11.195

8.  Reoperations after tricuspid valve repair.

Authors:  José M Bernal; Dieter Morales; Carmen Revuelta; Javier Llorca; Jesús Gutiérrez-Morlote; José M Revuelta
Journal:  J Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 5.209

9.  Immediate and long-term results of mitral prosthetic replacement using a right thoracotomy beating heart technique.

Authors:  M J Thompson; A Behranwala; C Campanella; W S Walker; E W J Cameron
Journal:  Eur J Cardiothorac Surg       Date:  2003-07       Impact factor: 4.191

10.  Isolated reoperative minimally invasive tricuspid valve operations.

Authors:  Bettina Pfannmüller; Martin Misfeld; Michael A Borger; Christian D Etz; Anne-Kathrin Funkat; Jens Garbade; Friedrich W Mohr
Journal:  Ann Thorac Surg       Date:  2012-09-07       Impact factor: 4.330

View more
  1 in total

Review 1.  Minimally invasive tricuspid valve surgery.

Authors:  Abdelrahman Abdelbar; Ayman Kenawy; Joseph Zacharias
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.